Treatment

Oligio Thermal RF Lifting

Oligio is a monopolar radiofrequency platform that heats the dermis, with collagen remodelling over the following months as the intended response. It is a dermal treatment and is not intended to reach the deeper SMAS plane that ultrasound lifting targets.

From KRW 430,000

≈ US$310

Cha-makase standard

Design before treatment

Every lifting treatment at Tune Clinic begins with Cha-makase design. The physician reads the whole face and marks the intended treatment zones and vectors before deciding the device, settings, shot count or thread direction.

This is a planning method, not a result guarantee. Suitability and the final plan are confirmed after an in-person assessment.

See the Cha-makase method

At a glance

Oligio Thermal RF Lifting
From KRW 430,000
Energy
Monopolar radiofrequency
Downtime
Redness, warmth or mild swelling can occur; how visible it is and how long it lasts vary by individual, and the physician confirms what to plan for
Result timing
Change from collagen remodelling develops gradually over months; the degree and timing vary by individual and are reviewed at follow-up
Areas
Face 300 or 600 shots; eye 200 or 400 shots

Why it works

01

Heat at the dermis

Monopolar radiofrequency passes energy through the skin to heat a broad column of dermis in a controlled way. Existing collagen fibres contract in the short term; over the following months the heated tissue remodels and produces new collagen.

02

Coverage over intensity

Oligio spreads energy over larger zones at moderate depth, which is a different delivery pattern rather than a better one. Comfort and response still vary by person and settings.

03

What it does not reach

Radiofrequency at these settings is applied to the skin layer and is not intended to reach the SMAS, the deeper structural plane that descends with age. If the physician assesses that most of the change you see comes from that plane, a dermal device may not be the right tool, and that is a conversation to have before booking.

Pricing

Oligio Thermal RF Lifting

From KRW 430,000

≈ US$310

300 shots or eye 200 shots from KRW 430,000; 600 shots or eye 400 shots KRW 820,000.

USD figures are approximate conversions at 1,380 KRW/USD (2026-09-12) for reference only; you pay in KRW.

Prices shown are the clinic's published KRW prices. Where a price is shown as a starting price, the final figure depends on the product, dose, and area chosen at the consultation. The physician confirms the plan and its price before treatment begins, and will tell you if the treatment is not suitable for you.

Treatment FAQ

Is Oligio just a cheaper Thermage?

Both are monopolar RF platforms targeting the dermis, and at comparable shot counts Oligio is published at roughly half the price on our menu. They are different platforms, so a lower price is not evidence that they are the same treatment, and it is equally not evidence that either performs better. Which one fits is an assessment question, not a price question.

How uncomfortable is Oligio?

Both platforms use cooling and vibration at the tip, and both can feel hot pulse by pulse. Comfort depends on settings, area, anesthesia and your own sensitivity, so this page does not rank the devices against each other for pain. Comfort measures are planned per patient and discussed before treatment.

How long do Oligio results last?

Collagen remodelling develops gradually over months rather than within the same week, and how much develops varies by individual. Whether and when to repeat is reassessed at follow-up rather than set as a fixed interval, and duration cannot be promised in advance.

Published research

What research can and cannot tell us

Monopolar radiofrequency as a class. This is modality context only. It is not evidence of Oligio's results, not evidence that Oligio is equivalent to Thermage, and it does not support the comparison, price, comfort or maintenance statements elsewhere on this page.

A small study of monopolar radiofrequency and microfocused ultrasound reported improvement in facial and neck laxity, but it does not establish results for Oligio or for any particular treatment plan.

A randomized split-face trial in 20 people followed for six months. Both sides improved with no significant difference between them, which is not evidence that the two treatments are equivalent, and the abstract does not name the commercial devices used.

This reference is background reading, not a claim about this clinic, its equipment or your own result. Suitability is decided at an in-person physician assessment.

Read the abstract on PubMed, PMID 30531187
WhatsAppCheck available dates